Financials
- Fiscal year
- 2025
- Total assets
- €1.1m
- Profit
- €26,934
- Solvency
- 24.7%
Total assets▼ 0.4%
Net result
20192025
Summary
EQUIBOR has a registered holding activity and consists mainly of financial fixed assets; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €276,355 and a net result of €26,934. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 45% of 72 sector peers (NACE 21, fiscal year 2025). The company has been active since 2018 and the Belgian State Gazette contains no insolvency or warning signals.
Overview
Activity
Manufacture of basic pharmaceutical products and pharmaceutical preparations
NACE 21100
1 site
Size
€1.1mtotal assets 2025
- Equity
- €276,355
- Profit
- €26,934
Turnover not published (abridged schema)
Financial health
Holding: outside the score modelProbability: sector outside the model
Structure
- Holdings
- 1
Accounts 36 days early0 of 4 deeds read
Signals+ Growing equityLatest accounts filed on timeShow the evidence
Checked score
Outside the general model
Holding: general score not applicable
The company has a registered holding activity and financial fixed assets account for more than half of its assets. The general operating-company model is unsuitable for this profile, so we show no financial axes either. Filed figures remain available.
Bankruptcy probability, 12 months
This is a financial institution (bank, insurer or financial holding). A bank balance sheet works differently from that of an ordinary trading or manufacturing company. We therefore show no bankruptcy probability rather than a misleading figure.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Two signals.
−lowers risk○neutral
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025Equity per financial year
19202122232425
2019 to 2025 · latest year €276,355
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 25-06-2026, 36 days ahead of the deadline.
NBB · 7 filingsDeviation from the deadline
2025
36 days early
2024
3 days early
2023
5 days late
2022
45 days early
2021
23 days early
2020
31 days late
2019
31 days late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 6 days before the deadline; the sector median for financial year 2024 is 9 days before the deadline, and 32% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 8 July (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven monthsPosition in the running window
07-10-2026 today31-12-2026 close31-07-2027 deadline
- Annual accounts filedfiscal year 2025 · micro…
- Annual accounts filedfiscal year 2024 · micro…
- Annual accounts filedfiscal year 2023 · micro…
Key points
By topic
Network & group
- Subsidiaries
- 2
- Holdings
- 1
2 subsidiaries
Timeline
- Events
- 10
- Since
- 2020
- Next accounts
- by 31-07-2027
- 31-12-2023Back to profit
- 31-12-2023Equity above €200,000
- 16-06-2023Annual accounts filed
Company details
- Sites
- 1
- Legal form
- Private limited company
- Activity
- Manufacture of basic pharmaceutical products and pharmaceutical preparationsNACE 21100
- Founded
- 23-10-2018
- Year ends
- 31-12
- Peppol
- Reachable for e-invoices
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What other support did companies like this one receive, and it did not?Subsidies What changed in the latest annual accounts?What changed
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.